These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1333012)
1. omega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists. Labaudinière R; Dereu N; Cavy F; Guillet MC; Marquis O; Terlain B J Med Chem; 1992 Nov; 35(23):4315-24. PubMed ID: 1333012 [TBL] [Abstract][Full Text] [Related]
2. omega-[(4-Phenyl-2-quinolyl)oxy]alkanoic acid derivatives: a new family of potent LTB4 antagonists. Labaudinière R; Hendel W; Terlain B; Cavy F; Marquis O; Dereu N J Med Chem; 1992 Nov; 35(23):4306-14. PubMed ID: 1333011 [TBL] [Abstract][Full Text] [Related]
3. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist. Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568 [TBL] [Abstract][Full Text] [Related]
4. (Phenylmethoxy)phenyl derivatives of omega-oxo- and omega-tetrazolylalkanoic acids and related tetrazoles. Synthesis and evaluation as leukotriene D4 receptor antagonists. Dillard RD; Hahn RA; McCullough D; Carr FP; Rinkema LE; Roman CR; Fleisch JH J Med Chem; 1991 Sep; 34(9):2768-78. PubMed ID: 1654427 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies. Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783 [TBL] [Abstract][Full Text] [Related]
6. Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones. Herron DK; Goodson T; Bollinger NG; Swanson-Bean D; Wright IG; Staten GS; Thompson AR; Froelich LL; Jackson WT J Med Chem; 1992 May; 35(10):1818-28. PubMed ID: 1316967 [TBL] [Abstract][Full Text] [Related]
7. Leukotriene B4 (LTB4) receptor antagonists: a series of (hydroxyphenyl)pyrazoles. Harper RW; Jackson WT; Froelich LL; Boyd RJ; Aldridge TE; Herron DK J Med Chem; 1994 Jul; 37(15):2411-20. PubMed ID: 8057289 [TBL] [Abstract][Full Text] [Related]
8. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696. Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764 [TBL] [Abstract][Full Text] [Related]
9. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 2. Structure-activity relationships of the lipophilic side chain. Gapinski DM; Mallett BE; Froelich LL; Jackson WT J Med Chem; 1990 Oct; 33(10):2807-13. PubMed ID: 2170648 [TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982. Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049 [TBL] [Abstract][Full Text] [Related]
11. Omega-[(omega-arylalkyl)thienyl]alkanoic acids: from specific LTA4 hydrolase inhibitors to LTB4 receptor antagonists. Labaudinière R; Hilboll G; Leon-Lomeli A; Terlain B; Cavy F; Parnham M; Kuhl P; Dereu N J Med Chem; 1992 Aug; 35(17):3170-9. PubMed ID: 1324316 [TBL] [Abstract][Full Text] [Related]
12. Effect of a leukotriene B4 receptor antagonist on leukotriene B4-induced neutrophil chemotaxis in cavine dermis. Fretland DJ; Widomski DL; Zemaitis JM; Djurić SW; Shone RL Inflammation; 1989 Oct; 13(5):601-5. PubMed ID: 2553605 [TBL] [Abstract][Full Text] [Related]